Advertisement

U.S. Markets closed

S&P Futures
4,054.00
-3.50(-0.09%)
Dow Futures
32,876.00
-27.00(-0.08%)
Nasdaq Futures
12,942.25
-22.75(-0.18%)
Russell 2000 Futures
1,781.60
-2.70(-0.15%)
Crude Oil
72.91
-0.06(-0.08%)
Gold
1,962.80
-4.10(-0.21%)

Advertisement

BICO Group AB (publ) (BICO.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK

52.24

-0.76

(-1.43%)

At close: 05:29PM CEST

Advertisement

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Business Wire
Lineage Broadens Collaboration With Advanced BioMatrix for HyStem® Cell Drug Delivery Technology
CARLSBAD, Calif., June 02, 2022--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has expanded its existing collaboration with Advanced BioMatrix, a division of BICO Group AB (STO: BICO), for Lineage’s HyStem cell/drug delivery technology. Under the expanded collaboration, Advanced BioMatrix will broaden its current focus of manufacturing and supplying R&D-g
Business Wire
Biosero, a Part of BICO Biosciences, Is Awarded a New Patent for Laboratory Automation Scheduling Software
GOTHENBURG, Sweden, May 24, 2022--The patent covers an approach that gives laboratories the ability to increase productivity for time and cost efficiencies.

Advertisement